10-73647531-A-AG
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001114133.3(SYNPO2L):c.2120dupC(p.Pro708fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000888 in 1,580,338 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00073 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00090 ( 2 hom. )
Consequence
SYNPO2L
NM_001114133.3 frameshift
NM_001114133.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.23
Genes affected
SYNPO2L (HGNC:23532): (synaptopodin 2 like) Predicted to enable actin binding activity. Predicted to be involved in several processes, including positive regulation of Rho protein signal transduction; positive regulation of stress fiber assembly; and sarcomere organization. Located in cell junction; cytosol; and nuclear speck. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNPO2L | NM_001114133.3 | c.2120dupC | p.Pro708fs | frameshift_variant | 4/4 | ENST00000394810.3 | NP_001107605.1 | |
SYNPO2L | NM_024875.5 | c.1448dupC | p.Pro484fs | frameshift_variant | 2/2 | NP_079151.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNPO2L | ENST00000394810.3 | c.2120dupC | p.Pro708fs | frameshift_variant | 4/4 | 1 | NM_001114133.3 | ENSP00000378289.2 | ||
SYNPO2L | ENST00000372873.8 | c.1448dupC | p.Pro484fs | frameshift_variant | 2/2 | 1 | ENSP00000361964.4 |
Frequencies
GnomAD3 genomes AF: 0.000722 AC: 105AN: 145460Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
105
AN:
145460
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00101 AC: 238AN: 236560Hom.: 0 AF XY: 0.00106 AC XY: 136AN XY: 127922
GnomAD3 exomes
AF:
AC:
238
AN:
236560
Hom.:
AF XY:
AC XY:
136
AN XY:
127922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000904 AC: 1297AN: 1434772Hom.: 2 Cov.: 37 AF XY: 0.000942 AC XY: 669AN XY: 710488
GnomAD4 exome
AF:
AC:
1297
AN:
1434772
Hom.:
Cov.:
37
AF XY:
AC XY:
669
AN XY:
710488
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000728 AC: 106AN: 145566Hom.: 0 Cov.: 31 AF XY: 0.000633 AC XY: 45AN XY: 71072
GnomAD4 genome
AF:
AC:
106
AN:
145566
Hom.:
Cov.:
31
AF XY:
AC XY:
45
AN XY:
71072
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | SYNPO2L NM_001114133.2 exon 4 p.Pro708Serfs*13 (c.2120dup): This variant has not been reported in the literature and is not present in large control databases. Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is a duplication of 1 cytosine nucleotide in a string of 7 cytosines and is predicted to create a premature stop codon 13 amino acids downstream from this location which results in an absent or abnormal protein. However, there is insufficient evidence to establish loss of function (LOF) as a known mechanism of disease. In addition, this variant occurs within the last exon of this gene; due to its position, it is possible that this protein may escape nonsense mediated decay. Further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at